title: Immunomodulation and adenoviral gene transfer to the lungs of nonhuman primates.
abstract: Previous data from our laboratory and others have demonstrated a critical role for the CD4+ T lymphocyte in in vivo immune responses to recombinant adenoviral vectors. In rodent models, this subset of T cells is required for T cell proliferation, subsequent cytotoxic T cell generation, and production of anti-adenoviral antibodies by B cells. Both depleting and nondepleting anti-CD4 antibodies can attenuate these immune responses to recombinant adenovirus. On the basis of these data, we hypothesized that a nondepleting CDR-engrafted anti-human CD4 antibody (OKT4A) with cross-reactivity to rhesus macaques would attenuate both T and B cell responses to intrapulmonary administration of recombinant adenovirus and permit prolonged reporter gene expression and permit secondary gene transfer. Juvenile rhesus macaques were treated with PBS or OKT4A antibody (10 mg/kg) daily beginning 1 day prior to and up to 11 days after gene transfer. OKT4A resulted in significant attenuation of lymphocyte recruitment into the lung, lymphocyte-proliferative responses to both adenovirus capsid proteins and transgene protein, and adenovirus-induced interferon-gamma elaboration in whole blood and hilar lymph nodes. However, OKT4A was ineffective in attenuating adenovirus-induced IL-4 production in whole blood or hilar lymph nodes, generating neutralizing anti-adenoviral antibodies, or permitting secondary gene transfer. As all the monkeys in this protocol had baseline-detectable anti-adenoviral antibodies by ELISA that were nonneutralizing, analogous to most patients with cystic fibrosis, we postulate that anti-CD4 did not block the proliferation of memory B cells. Moreover, these data suggest that for transient immunomodulation to be successful, strategies need to focus specifically on B cell activation independent of CD4+ T cell help.
authors.affiliation: LSU Gene Therapy Program, New Orleans, LA 70112, USA.
authors.forename: M K
authors.initials: MK
authors.lastname: Shean
authors.forename: G
authors.initials: G
authors.lastname: Baskin
authors.forename: D
authors.initials: D
authors.lastname: Sullivan
authors.forename: J
authors.initials: J
authors.lastname: Schurr
authors.forename: D E
authors.initials: DE
authors.lastname: Cavender
authors.forename: J E
authors.initials: JE
authors.lastname: Shellito
authors.forename: P O
authors.initials: PO
authors.lastname: Schwarzenberger
authors.forename: J K
authors.initials: JK
authors.lastname: Kolls
mesh_terms: D000256:Adenoviridae / Q000235:genetics* / Q000276:immunology*; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D015704:CD4 Antigens / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000493:pharmacokinetics; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D008168:Lung / Q000276:immunology* / Q000473:pathology / Q000821:virology; D008198:Lymph Nodes / Q000276:immunology / Q000378:metabolism; D008253:Macaca mulatta; D011014:Pneumonia / Q000235:genetics / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D015704:CD4 Antigens; D015847:Interleukin-4; D007371:Interferon-gamma